In contrast to growth hormone receptor resistance and more distal disturbances such as IGF-1 receptor deficiency, the administration of proper recombinant growth hormone circumvents both the quantitative and qualitative disorders in the production and secretion of growth hormone, as well as defects in the endogenous protein structure. This evidence concerns the gene GHR and hyperinsulinemic hypoglycemia, familial, 4.